ADDYI
NDC 58604-214, flibanserin, tablet, film coated, from Sprout Pharmaceuticals, Inc..
- Product NDC
- 58604-214
- Status
- Listed
- Labeler
- Sprout Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022526
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58604-214 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FLIBANSERIN100 mg/1
Pharmacologic classes
P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58604-214-30 | 58604021430 | 1 BOTTLE in 1 CARTON (58604-214-30) / 30 TABLET, FILM COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3819daf3-e935-2c53-c527-e1d57922f394
Use it
Look up 58604-214 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58604-214 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58604-214. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.